Work

Genetically informed search for potential osteoarthritis drug targets across the proteome

Year: 2026
Type: article
Study design: Observational Study
Abstract: Objective: Osteoarthritis (OA) is a leading cause of disability, yet no licensed therapies can prevent or slow its progression. We aimed to identify potential disease-modifying OA drug (DMOAD) targets by integrating genetic and differential protein abundance (DPA) evidence. Method: -pQTLs) across three European cohorts (UK Biobank Pharma Proteomics Project, deCODE, and Fenland) and outcome data from the Genetics of Osteoarthritis Consortium across 11 OA phenotypes. Following limit-of-detection and missingness filtering, DPA evaluated 2133 proteins in 7186 prevalent OA cases and 29,584 controls from UK Biobank. MR-prioritised proteins were further assessed using summary-data-based Mendelian randomisation (SMR) with OA joint-tissue eQTL data, alongside pathway, protein-interaction, and druggability analyses. Results: -MR and colocalisation prioritised 81 proteins, of which 30 showed joint-tissue transcriptomic support in SMR analyses. DPA identified 1436 proteins associated with ≥1 OA phenotype, of which 1314 (91.5%) retained significance in sensitivity analyses. Seventeen proteins had matched MR and DPA support, including three Tier 1 druggable targets (DLK1, SOST, and TNFRSF9); seven of these had SMR support. EHBP1, LGALS3, and OGN showed concordant DPA and MR effects and cross-platform evidence. EHBP1, PCSK7 and ITIH4 emerged as under-recognised candidates. Pathway analyses recapitulated established OA processes, while drug enrichment identified hypothesis-generating compounds. Conclusion: -MR, colocalisation, DPA, and tissue-specific transcriptomic evidence prioritised several potential OA therapeutic targets. DLK1, LGALS3, OGN and EHBP1 emerged as high-priority candidates, while EHBP1, PCSK7 and ITIH4 represent under-recognised candidates warranting functional investigation.
Language: English
Subfield: Rheumatology
Field: Medicine
Open Access status: gold
Estimated APC paid: $1,610
OpenAlex ID: W7223466729
FWCI:
Cites: 70
Cited by:
Related to: 10